Formulation Strategies for Improved Delivery of Biologics

The safety and efficacy of protein and peptide therapeutics are limited by in vitro and in vivo instability, immunogenicity and short circulating half-lives. CHI's Inaugural Formulation Strategies or Improved Delivery of Biologics conference will discuss new formulation approaches designed to overcome biologics delivery issues through as chemical modifications, new formulations and delivery technologies and advanced analytical tools to characterize protein interactions with excipients. These strategies have the potential to facilitate the development of next generation peptide and protein therapeutics which are safe, efficacious and promote patient compliance.